Dr John J Brinkman Jr, PHD | |
7956 W Jefferson Blvd, Fort Wayne, IN 46804-4140 | |
(260) 436-2416 | |
Not Available |
Full Name | Dr John J Brinkman Jr |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 7956 W Jefferson Blvd, Fort Wayne, Indiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134241227 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103T00000X | Psychologist | 20042066A (Indiana) | Secondary |
103G00000X | Clinical Neuropsychologist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr John J Brinkman Jr, PHD 7956 W Jefferson Blvd, Fort Wayne, IN 46804-4140 Ph: (260) 436-2416 | Dr John J Brinkman Jr, PHD 7956 W Jefferson Blvd, Fort Wayne, IN 46804-4140 Ph: (260) 436-2416 |
News Archive
Propanc Health Group Corporation, an emerging healthcare company that focuses on the development of new and proprietary treatments for cancer patients, is pleased to announce it has executed an equity purchase agreement (the "EPA") with Southridge Partners II, L.P., an institutional investor, in the amount of $5 million, which will create significant growth capital for Propanc, enabling the execution of its business plan, on favorable terms.
Researchers from the University of Toronto have found that a specific cell type plays a key role in maintaining healthy arteries after inflammation. It's a discovery that could provide treatment options for cardiovascular disease - one of the leading causes of death in Canada.
BBI Solutions today announced the launch of Porcine Liver Esterase (PLE), a new enzyme for Urinalysis, which is available to sample now.
A retrospective study of almost 39,000 patients shows that opportunities to diagnose chronic obstructive pulmonary disease (COPD) at an earlier stage are frequently being missed in both primary and secondary care in the UK. The findings, published in The Lancet Respiratory Medicine, reveal missed opportunities to diagnose COPD occurred in up to 85% of people.
› Verified 4 days ago